NASDAQ: LGVNLongeveron Inc Stock Ownership - Who owns Longeveron?
Insider buying vs selling
Have Longeveron Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen H. Willard | Chief Executive Officer | 2026-03-02 | 105,533 | $0.55 | $57.52kSell |
| Devin Blass | CTO SVP of CMC | 2026-01-02 | 10,700 | $0.59 | $6.35kSell |
| James Nathaniel Powell | Chief Executive Officer | 2026-01-02 | 2,464 | $0.59 | $1.46kSell |
| Nataliya Agafonova | Chief Medical Officer | 2026-01-02 | 10,250 | $0.59 | $6.08kSell |
| Lisa Locklear | Chief Financial Officer | 2026-01-02 | 10,250 | $0.59 | $6.08kSell |
| Paul T. Lehr | General Counsel Secretary | 2026-01-02 | 6,952 | $0.59 | $4.12kSell |
| James Nathaniel Powell | Chief Executive Officer | 2025-10-01 | 2,389 | $0.74 | $1.77kSell |
| Lisa Locklear | Chief Financial Officer | 2025-10-01 | 11,883 | $0.74 | $8.82kSell |
| Paul T. Lehr | General Counsel Secretary | 2025-10-01 | 4,944 | $0.74 | $3.67kSell |
| Nataliya Agafonova | Chief Medical Officer | 2025-10-01 | 11,883 | $0.74 | $8.82kSell |
LGVN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LGVN insiders and whales buy or sell their stock.
LGVN Shareholders
What type of owners hold Longeveron Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donald M. Soffer | 64.30% | 13,717,945 | $13.36M | Insider |
| Joshua Hare | 3.63% | 775,310 | $755.15k | Insider |
| Vanguard Group Inc | 2.34% | 499,126 | $486.15k | Institution |
| Mohamed Wael Ahmed Hashad | 1.97% | 420,904 | $409.96k | Insider |
| Paul T. Lehr | 1.61% | 344,177 | $335.23k | Insider |
| Lisa Locklear | 1.07% | 228,831 | $222.88k | Insider |
| Rock Soffer | 1.06% | 226,034 | $220.16k | Insider |
| Nataliya Agafonova | 1.02% | 216,564 | $210.93k | Insider |
| Devin Blass | 0.94% | 200,176 | $194.97k | Insider |
| Geode Capital Management LLC | 0.66% | 141,501 | $137.82k | Institution |
LGVN vs Biotech Stocks
Longeveron Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.